Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prostate Adenocarcinoma TransCutaneous Hormones (PATCH)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Imperial College London
Sponsor:
Collaborators:
Medical Research Council
University College, London
Information provided by (Responsible Party):
Imperial College London
ClinicalTrials.gov Identifier:
NCT00303784
First received: March 15, 2006
Last updated: October 26, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2021
  Estimated Primary Completion Date: August 2021 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):